06:40 AM EDT, 04/03/2025 (MT Newswires) -- Novo Nordisk ( NVO ) said Thursday that Executive Vice President of Commercial Strategy and Corporate Affairs Camilla Sylvest has decided to depart.

The company said EVP of Rare Disease Ludovic Helfgott will assume the responsibility for product and portfolio strategy, while Senior Vice President of Product Supply Emerging Technologies Thilde Hummel Bogebjerg was promoted to EVP of quality, IT and environmental affairs.

EVP of People and Organization Tania Sabroe is assuming the additional responsibility for global communication, the company said.